{"nct_id":"NCT04581824","title":"Efficacy Comparison of Dostarlimab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Participants With Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)","status":"TERMINATED","status_verified_date":"2025-07","start_date":"2020-11-19","start_date_type":"ACTUAL","primary_completion_date":"2022-08-04","primary_completion_date_type":"ACTUAL","completion_date":"2024-09-10","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}